Abstract
PURPOSEAdvances in precision oncology, including RAS testing to predict response to epidermal growth factor receptor monoclonal antibodies (EGFR mAbs) in colorectal cancer (CRC), can extend patient...
Cite
CITATION STYLE
APA
Becker, D. J., Lee, K. M., Lee, S. Y., Lynch, K. E., Makarov, D. V., Sherman, S. E., … Lynch, J. A. (2021). Uptake of KRAS Testing and Anti-EGFR Antibody Use for Colorectal Cancer in the VA. JCO Precision Oncology, (5), 638–645. https://doi.org/10.1200/po.20.00359
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free